Skip to main content

Table 5 Factors associated with non-susceptibility to ciprofloxacin, nalidixic acid or erythromycin among a cohort of Campylobacter-associated hospitalisations (n = 548)

From: Bacteraemia, antimicrobial susceptibility and treatment among Campylobacter-associated hospitalisations in the Australian Capital Territory: a review

Predictor variable Estimated adjusted Odds Ratio (aOR) 95 % Confidence Interval p-value
Recent overseas travel 11.80 3.18–43.83 < 0.001
Previous Campylobacter-associated hospitalisation 17.09 2.65−110.07 < 0.01
Tachycardia 0.48 0.26–0.89 0.02
  1. Hosmer and Lemeshow goodness of fit χ2  = 0.01,  p = 0.92